USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Technology Developments Fuelling Growth Opportunities for Cannabinoids
Technology Developments Fuelling Growth Opportunities for Cannabinoids
Analysis of Cross Sector Adoption and Ancillary Business Capabilities of Cannabinoids
RELEASE DATE
14-Dec-2020
14-Dec-2020
REGION
Global
Global
Research Code: D9DD-01-00-00-00
SKU: FN00039-GL-TR_25035
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
FN00039-GL-TR_25035
Description
Cannabinoids as an ingredient for use in pharmaceuticals, F&B and other industries is steadily gaining in interest across the globe, While R&D and technology developments are on the rise, the industry is still emerging considering the regulatory scenario and the technology limitations. With many technology developers focusing on overcoming challenges and product developmental efforts, new business models need to play with all possible interactions among stakeholders in order to create a smooth environment for commercialization. In countries such as USA, advancing regulations is encouraging the innovation ecosystem to flourish and new commercialization opportunities are expected to rise in the coming 3-5 years. Competition models are gaining increasing attention in order to face challenges and capture value. Technology and business synergies are required to optimal route for commercialization with industry convergence needed to diversify the business opportunities across industries.
Table of Contents
1.1 The Strategic Imperative 8™
1.2 The Strategic Imperative 8™
1.3 The Impact of the Top Three Strategic Imperatives on Cannabinoids Technology
1.4 About the Growth Pipeline Engine™
1.5 Growth Opportunities Fuel the Growth Pipeline Engine™
2.1 Research Scope
2.2 Research Methodology
2.3 Key Findings – Prompt Benefits for Patients and Consumers Increasing Adoption
2.4 Key Findings – Solid, Well Branded Developmental Networks to Increase Commercialization
2.5 Summary of Growth Opportunities – Cannabinoids Production
2.6 Summary of Growth Opportunities – Ancillary Business Development
3.1 Characteristics of Cannabinoids and the Endocannabinoid System
3.2 Cannabinoids Chemotypes and Classification
3.3 Cannabinoids Synthesis and Mechanism of Action
3.4 Key Cannabinoids of Commercial Interest
3.5 Psychoactive Cannabinoids and Therapeutic Indications
3.6 Non Psychoactive Cannabinoids and Therapeutic Indications
3.7 Mapping of Overall Beneficial Effects of Cannabinoids
4.1 Key Enabling Technologies that Influence Cannabinoids Production
4.2 Key Enabling Technologies that Influence Cannabinoids Formulation
4.3 Smart Agriculture and Synthetic Biology Approaches for Cannabinoids Production
4.4 Cannabinoids Production: Comparison of Smart Agriculture and Synthetic Biology Approaches
5.1 Important Regulatory Concerns Around Cannabinoids
5.2 Cannabinoids Worldwide Legality Status
5.3 Regulatory Framework for CBD Therapy Approval
6.1 Key Market Participants in Cannabinoids Across Various Application Sectors
7.1 Commercialized Products Dashboard Bedrocan®, Bedrobinol®, Bediol®, Bedica®, Bedrolite®
7.2 Commercialized Products Dashboard Marinol®, Syndros®, Cesamet®
7.3 Commercialized Products Dashboard Sativex®, Epidiolex®
7.4 Dashboard of Products in Pipeline Namisol®, Arvisol®, Polyfunctional Cannabinoids, Drug Delivery
7.5 Dashboard of Products in Pipeline: Cannabinoids Programs
8.1 Commercialized Products Dashboard : Major Cannabinoid-based Food and Supplements Products Brands
9.1 Commercialized Products Dashboard: Cannabinoid-based Personal Care and Cosmetics Brands
10.1 Commercialized Products Dashboard: Cannabinoid-based Hemp Textile Product Brands
11.1 Commercialized Product Dashboard: Major Cannabinoid-based Hemp Feedstocks Brands
12.1 Cannabinoids Adoption Gaining Momentum Across Industries in the US
12.2 Focus of VC Funding Remains Stable in North America
12.3 Snapshot of Funding and Investment Scenario in US
12.4 Market Value and Capitalization of Key Participants
13.1 Growth Opportunity 1: Standardized Active Pharmaceutical Ingredients (API) for Introduction in Novel Therapeutics, 2020
13.1 Growth Opportunity 1: Standardized Active Pharmaceutical Ingredients (API) for Introduction in Novel Therapeutics, 2020
13.2 Growth Opportunity 2: Cost-effective and Scalable Manufacturing for Product Quality and Process Sustainability, 2020
13.2 Growth Opportunity 2: Cost-effective and Scalable Manufacturing for Product Quality and Process Sustainability, 2020
13.3 Growth Opportunity 3: Mechanism of Action of Individual Cannabinoids for Enhanced Products with Rare Cannabinoids, 2020
13.3 Growth Opportunity 3: Mechanism of Action of Individual Cannabinoidsfor Enhanced Products with Rare Cannabinoids, 2020
13.4 Growth Opportunity 4: Internationally Consistent Regulatory Framework for Interstate, Intercontinental, Global Commercialization, 2020
13.4 Growth Opportunity 4: Internationally Consistent Regulatory Framework for Interstate, Intercontinental, Global Commercialization, 2020
13.5 Growth Opportunity 5: Ancillary Businesses for Value Chain Enhancement, 2020
13.5 Growth Opportunity 5: Ancillary Businesses for Value Chain Enhancement, 2020
13.6 Growth Opportunity 6: Product Portfolio Diversification Across Industries for a Comprehensive Cannabinoid Value Proposition, 2020
13.6 Growth Opportunity 6: Product Portfolio Diversification Across Industries for a Comprehensive Cannabinoid Value Proposition, 2020
14.1 Companies to Watch
14.1 Companies to Watch (continued)
14.1 Companies to Watch (continued)
14.1 Companies to Watch (continued)
15.1 Your Next Steps
15.2 Why Frost, Why Now?
Legal Disclaimer
Popular Topics
Cannabinoids as an ingredient for use in pharmaceuticals, F&B and other industries is steadily gaining in interest across the globe, While R&D and technology developments are on the rise, the industry is still emerging considering the regulatory scenario and the technology limitations. With many technology developers focusing on overcoming challenges and product developmental efforts, new business models need to play with all possible interactions among stakeholders in order to create a smooth environment for commercialization. In countries such as USA, advancing regulations is encouraging the innovation ecosystem to flourish and new commercialization opportunities are expected to rise in the coming 3-5 years. Competition models are gaining increasing attention in order to face challenges and capture value. Technology and business synergies are required to optimal route for commercialization with industry convergence needed to diversify the business opportunities across industries.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Cecilia Van Cauwenberghe |
| Industries | Agriculture and Nutrition |
| WIP Number | D9DD-01-00-00-00 |
| Is Prebook | No |